Predicate |
Object |
contentType |
Journal Article |
endingPage |
2; author reply 1402 |
issn |
1522-9645 0195-668X |
issueIdentifier |
11 |
pageRange |
1401-2; author reply 1402 |
publicationName |
European Heart Journal |
startingPage |
1401 |
bibliographicCitation |
Scheen AJ, Van Gaal LF. Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes. Eur Heart J. 2007 Jun;28(11):1401–2; author reply 1402. doi: 10.1093/eurheartj/ehm123. PMID: 17493946. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7ac7478d593e5f4a7ca4e75719c4983 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb9f708c26c9317d0d3e3f23c4ad05c5 |
date |
2007-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/17493946 https://doi.org/10.1093/eurheartj/ehm123 |
isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3586 https://portal.issn.org/resource/ISSN/0195-668X https://portal.issn.org/resource/ISSN/1522-9645 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes |
discusses |
http://id.nlm.nih.gov/mesh/M0235470 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0010903 http://id.nlm.nih.gov/mesh/M0016885 |
hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D007004Q000627 http://id.nlm.nih.gov/mesh/D011720Q000627 http://id.nlm.nih.gov/mesh/D003924Q000188 http://id.nlm.nih.gov/mesh/D009765Q000150 http://id.nlm.nih.gov/mesh/D010880Q000627 |
hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D000077285 http://id.nlm.nih.gov/mesh/D017024 http://id.nlm.nih.gov/mesh/D006801 |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7444 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10897 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8679 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104850 |